Claritin®
Efficacy

 

 

Claritin®
Efficacy

 

A Clear Choice for Well-Proven Relief
From Allergic Rhinitis Symptoms1

A Clear Choice for Well-Proven Relief From Allergic Rhinitis Symptoms1

Claritin® allergy symptom relief chart in comparison with placebo.
Claritin® allergy symptom relief chart in comparison with placebo.

 

 

 

Loratadine, the active ingredient in Claritin®, provides relief of a wide range of symptoms associated with SAR.

  • Significantly greater symptom relief than placebo for all AR symptoms tested.

*Also available in other formulations.

†Claritin® is not indicated for relief of itching ears or palate, or red, puffy eyes.

‡P<0.05 vs loratadine.

Adapted from Kaiser et al, 2008.

Post-hoc analysis of day 2 data from a 7 day randomized, placebo-controlled, double-blind, double-dummy study involving 835 subjects aged 12 to 60 years with a ≥2-year history of SAR.

AR=allergic rhinitis; qd=once daily; SAR=seasonal allergic rhinitis.

 

Claritin® Provides Consistent Symptom
Relief From Day 1 up to 7 Days vs Placebo2

Claritin® Provides Consistent Symptom Relief From Day 1 up to 7 Days vs Placebo2

Improvement in total symptom severity chart.
Improvement in total symptom severity chart.

 

 

 

A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study involving 836 subjects aged 12 to 60 years with a ≥2-year history of spring and summer SAR.2

qd=once daily; TSS=total symptom severity scores; SAR=seasonal allergic rhinitis.

 

Claritin®: The Clear Choice to Help
Improve Patients’ Quality of Life3,†

Claritin®: The Clear Choice to Help Improve Patients’ Quality of Life3,†

Chart depicting improvement in quality of life with loratadine.
Chart depicting improvement in quality of life with loratadine.

 

 

Loratadine, the active ingredient in Claritin®, improved quality of life 52% greater than placebo.

*P≤0.001 vs placebo.

†Based on overall (mean of 7 domains) rhinoconjunctivitis quality of life scores after 2 weeks of treatment.

Adapted from Philip et al, 2002.

A multicenter, randomized, double-blind, placebo- and active-controlled trial involving 1302 adult patients (15 to 81 years) with active allergic rhinitis symptoms. In this study montelukast was compared with loratadine and placebo.

CI=confidence interval; LS=least squares.

Trust the Heritage of Claritin® in Treating Allergic Rhinitis

Claritin® is no.1 doctor recommended OTC allergy brand.

Clinically proven allergy relief for approximately 90,000 subjects aged 12 years and older have been treated with loratadine (10 mg, once daily) in controlled and uncontrolled clinical trials5

  • Claritin® is available in over 100 countries.4
  • Loratadine products have a total estimated exposure of more than 29 billion patient treatment days.4
  • Loratadine products have over 30 years of patient use.4

*Among oral OTC non-drowsy allergy brands.

See Tolerability Data

 

Trust the Heritage of Claritin® in Treating Allergic Rhinitis

Claritin® is no.1 doctor recommended OTC allergy brand.

 

Clinically proven allergy relief for approximately 90,000 subjects aged 12 years and older have been treated with loratadine (10 mg, once daily) in controlled and uncontrolled clinical trials5

  • Claritin® is available in over 100 countries.4
  • Loratadine products have a total estimated exposure of more than 29 billion patient treatment days.4
  • Loratadine products have over 30 years of patient use.4

 

*Among oral OTC non-drowsy allergy brands.

See Tolerability Data

 

Claritin® Patient Types

  • Patients concerned about drowsiness.
  • Includes professional drivers, pilots, machinery operators, etc.
  • Patients seeking 24 hour relief.
  • Patients with allergies, without nasal congestion.
  • Patients who appreciate the varied forms, who want an on-the-go solution: chewables, Redi-Tabs, liquid-gels or tablets.
  • Patients with indoor or outdoor allergies.

 

 

Claritin® Patient Types

  • Patients concerned about drowsiness.
  • Includes professional drivers, pilots, machinery operators, etc.
  • Patients seeking 24 hour relief.
  • Patients with allergies, without nasal congestion.
  • Patients who appreciate the varied forms, who want an on-the-go solution: chewables, Redi-Tabs, liquid-gels or tablets.
  • Patients with indoor or outdoor allergies.

 

 

 

 

 

Order Samples and Coupons for Your Patients

Claritin® offers allergy relief for kids and adults in a variety of forms and flavors. Help your patients tackle their tough allergy symptoms with samples and coupons for Claritin® products.

Order Patient Resources

 

 

Order Samples and Coupons for Your Patients

Claritin® offers allergy relief for kids and adults in a variety of forms and flavors. Help your patients tackle their tough allergy symptoms with samples and coupons for Claritin® products.

Order Patient Resources

 

 

References

  1. Kaiser HB, Gopalan G, Chung W. Loratadine provides early symptom control in seasonal allergic rhinitis. Allergy Asthma Proc. 2008;29:654-658.
  2. Kaiser HB, Rooklin A, Spangler D, Capano D. Efficacy of loratadine compared with fexofenadine or placebo for the treatment of seasonal allergic rhinitis. Clin Drug Invest. 2001;21(8):571-578.
  3. Philip G, Malstrom K, Hampel Jr. FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 2002;32(7):1020-1028.
  4. Data on file. Bayer Pharmaceuticals.
  5. Claritin®. Prescribing information. Schering Corporation; 2000.